z-logo
Premium
ECTO 5‘‐NUCLEOTIDASE ACTIVITY IN LYMPHOCYTES IN CASES OF UVEITIS
Author(s) -
UUSITALO RISTO J.,
UUSITALO HANNU,
PALKAMA ARTO
Publication year - 1983
Publication title -
acta ophthalmologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.534
H-Index - 87
eISSN - 1755-3768
pISSN - 1755-375X
DOI - 10.1111/j.1755-3768.1983.tb01434.x
Subject(s) - uveitis , lymphocyte , etiology , medicine , immunology , intermediate uveitis , 5' nucleotidase , disease , pathology , anterior uveitis , adenosine
This study attempts to demonstrate cellular reactivity in cases of uveitis. Lymphocyte AMPase activity was measured in 59 patients with uveitis of different types, all in the active stage. The patients were divided into 3 groups: 1) anterior uveitis with known disease, 2) anterior uveitis with unknown aetiology, and 3) posterior uveitis. The AMPase activity in peripheral lymphocytes from uveitis patients with known disease (group 1) was significantly decreased in comparison to lymphocytes from controls. Patients having endogenous uveitis (unknown aetiology, group 2) showed heterogeneity concerning their enzyme activity, and no significant changes were demonstrated. A subpopulation of patients with very low AMPase activity in the active stage of their disease could be defined. Patients with posterior uveitis showed no change in their lymphocyte AMPase activity. B‐cells were also counted in cell suspension to verify that there was no selective change in the B‐cells. Cell suspensions from patients with low and normal AMPase activities were studied by the electron microscope and found to have similar proportions of different types of mononuclear cells. Enzyme deficiencies in lymphocytes were associated with immunological disorders and would reflect dysfunction of lymphocytes. The heterogenous results from patients with endogenous uveitis were interpreted as showing cellular reactivity to ocular damage caused by a variety of mechanisms.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here